First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trialGareth J. Morgan, J. Anthony Child, Graham Jackson et al.|The Lancet|2010Cited by 571
Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed MyelomaBrian A. Walker, Gareth J. Morgan, Eileen M. Boyle et al.|Journal of Clinical Oncology|2015Cited by 564
Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survivalRichard Kelly, Peter Hillmen, Anita Hill et al.|Blood|2011Cited by 514
Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX StudyAndy C. Rawstron, Roger G. Owen, J. A. Child et al.|Journal of Clinical Oncology|2013Cited by 419
Inadequacy of iridium implant as sole radiation treatment for operable breast cancerIan S. Fentiman, R.D. Rubens, Christopher Poole et al.|European Journal of Cancer|1996Cited by 177